Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy
Deeba Shamim Jairajpuri, Taj Mohammad, Kirtika Adhikari, et al.
ACS Omega (2020) Vol. 5, Iss. 24, pp. 14720-14729
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches
Agneesh Pratim Das, Subhash Mohan Agarwal
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 901-925
Open Access | Times Cited: 25
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy
Mohd Yousuf, Parvez Κhan, Anas Shamsi, et al.
ACS Omega (2020) Vol. 5, Iss. 42, pp. 27480-27491
Open Access | Times Cited: 66
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
Yanhong Bu, Hong Wu, Ran Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 41
Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications
Urooj Fatima, Sonam Roy, Shahnawaz Ahmad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113469-113469
Closed Access | Times Cited: 34
Pharmacological features, health benefits and clinical implications of honokiol
Fatima Khatoon, Sabeeha Ali, Vijay Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 15, pp. 7511-7533
Closed Access | Times Cited: 28
Identifying potential inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase: Molecular dynamic insights into the interaction and inhibitory mechanism
Taj Mohammad, Afzal Hussain, Mohamed F. Alajmi, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100458-100458
Open Access | Times Cited: 5
Structure-guided identification of potential MTH1 inhibitors from natural compounds: toward therapeutic targeting of oxidative DNA damage in cancer
Aaliya Taiyab, Taj Mohammad, Md Nayab Sulaimani, et al.
Chemical Papers (2025)
Closed Access
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
Sonam Roy, Taj Mohammad, Preeti Gupta, et al.
ACS Omega (2020) Vol. 5, Iss. 34, pp. 21550-21560
Open Access | Times Cited: 47
Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies
Asifa Khan, Taj Mohammad, Anas Shamsi, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10319-10331
Closed Access | Times Cited: 36
Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
Alaa Shafie, Shama Khan, Zehra, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2157-2157
Open Access | Times Cited: 36
Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies
Mohd Yousuf, Anas Shamsi, Aarfa Queen, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 8, pp. 897-910
Closed Access | Times Cited: 32
Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy
Bin Xue, Debarati DasGupta, Manzar Alam, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 8, pp. 1381-1393
Closed Access | Times Cited: 19
Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics
Mohd Yousuf, Anas Shamsi, Shama Khan, et al.
International Journal of Biological Macromolecules (2022) Vol. 213, pp. 944-954
Open Access | Times Cited: 18
Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach
Bader S. Alotaibi, Jatin Joshi, Mohammad Raghibul Hasan, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6749-6758
Closed Access | Times Cited: 16
Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy
Md. Imtaiyaz Hassan, Darakshan Anjum, Taj Mohammad, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 10558-10568
Closed Access | Times Cited: 16
Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy
Sonam Roy, Shama Khan, Deeba Shamim Jairajpuri, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 14, pp. 6350-6362
Closed Access | Times Cited: 22
Probing Baicalin as potential inhibitor of Aurora kinase B: A step towards lung cancer therapy
Saba Noor, Arunabh Choudhury, Ali Raza, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128813-128813
Closed Access | Times Cited: 8
Thymoquinone, artemisinin, and thymol attenuate proliferation of lung cancer cells as Sphingosine kinase 1 inhibitors
Ilma Shakeel, Shaista Haider, Shama Khan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117123-117123
Open Access | Times Cited: 2
Impact of non-synonymous mutations on the structure and function of telomeric repeat binding factor 1
Insan Habib, Shama Khan, Taj Mohammad, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 19, pp. 9053-9066
Closed Access | Times Cited: 19
Exploring binding mechanism of naringenin to human transferrin using combined spectroscopic and computational methods: Towards therapeutic targeting of neurodegenerative diseases
Shama Khan, Fahad A. Alhumaydhi, Mohd Shahnawaz Khan, et al.
Journal of Molecular Liquids (2022) Vol. 356, pp. 119001-119001
Closed Access | Times Cited: 11
LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression
Xin Wang, Hongtao Liu, Qing Zhang, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 5
Open Access | Times Cited: 15
Synthesis, anticancer activity and molecular modeling study of novel substituted triazole linked tetrafluoronaphthalene hybrid derivatives
Musa Erdoğan, Ferah Cömert Önder
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9767-9786
Open Access | Times Cited: 5
Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat
Stefania Elena Navone, Laura Guarnaccia, Massimiliano D. Rizzaro, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 130-130
Open Access | Times Cited: 5
Identification of Potential Bioactive Phytochemicals for the Inhibition of Platelet-Derived Growth Factor Receptor β: An integrated docking and MD simulation approach
Insan Habib, Md Nayab Sulaimani, Afzal Hussain, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Elucidating the interactions of advanced glycation end products with RAGE, employing molecular docking and MD simulation approaches: Implications of potent therapeutic for diabetes and its related complications
Chandni Hayat, Muhammad Yaseen, Sajjad Ahmad, et al.
Journal of Molecular Liquids (2024) Vol. 416, pp. 126467-126467
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top